DE69924710D1 - Pharmazeutische zubereitung zur anwendung in der antiasthmatherapie - Google Patents

Pharmazeutische zubereitung zur anwendung in der antiasthmatherapie

Info

Publication number
DE69924710D1
DE69924710D1 DE69924710T DE69924710T DE69924710D1 DE 69924710 D1 DE69924710 D1 DE 69924710D1 DE 69924710 T DE69924710 T DE 69924710T DE 69924710 T DE69924710 T DE 69924710T DE 69924710 D1 DE69924710 D1 DE 69924710D1
Authority
DE
Germany
Prior art keywords
antiasthmatherapy
application
pharmaceutical preparation
pharmaceutical
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69924710T
Other languages
English (en)
Other versions
DE69924710T2 (de
Inventor
Nipun Davar
D Ayer
M Hwang
J Pollock
Padmaja Shivanand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of DE69924710D1 publication Critical patent/DE69924710D1/de
Publication of DE69924710T2 publication Critical patent/DE69924710T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69924710T 1998-03-06 1999-02-26 Pharmazeutische zubereitung zur anwendung in der antiasthmatherapie Expired - Fee Related DE69924710T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7709198P 1998-03-06 1998-03-06
US77091P 1998-03-06
PCT/US1999/004350 WO1999044592A1 (en) 1998-03-06 1999-02-26 Anti-asthma therapy

Publications (2)

Publication Number Publication Date
DE69924710D1 true DE69924710D1 (de) 2005-05-19
DE69924710T2 DE69924710T2 (de) 2005-09-15

Family

ID=22136018

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69924710T Expired - Fee Related DE69924710T2 (de) 1998-03-06 1999-02-26 Pharmazeutische zubereitung zur anwendung in der antiasthmatherapie

Country Status (10)

Country Link
US (1) US6224907B1 (de)
EP (1) EP1059917B1 (de)
JP (1) JP2002505275A (de)
AR (1) AR018582A1 (de)
AT (1) ATE292960T1 (de)
AU (1) AU2882299A (de)
DE (1) DE69924710T2 (de)
ES (1) ES2237088T3 (de)
HK (1) HK1033278A1 (de)
WO (1) WO1999044592A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6706283B1 (en) * 1999-02-10 2004-03-16 Pfizer Inc Controlled release by extrusion of solid amorphous dispersions of drugs
CA2382834A1 (en) * 1999-09-20 2001-03-29 Alza Corporation Process for lessening polymorphic conversion of a drug
KR100381834B1 (ko) * 2000-05-20 2003-04-26 이상득 용출성이 개선된 프란루카스트 고체분산체 조성물 및 그제조 방법
US20050070487A1 (en) * 2001-04-24 2005-03-31 Nyce Jonathan W. Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
MY148466A (en) * 2001-10-26 2013-04-30 Merck Frosst Canada Ltd Granule formulation
US20030175346A1 (en) * 2002-02-01 2003-09-18 Anne Billotte Osmotic delivery system
US20030161882A1 (en) * 2002-02-01 2003-08-28 Waterman Kenneth C. Osmotic delivery system
US7226422B2 (en) 2002-10-09 2007-06-05 Cardiac Pacemakers, Inc. Detection of congestion from monitoring patient response to a recumbent position
US7148248B2 (en) * 2002-11-29 2006-12-12 Masako Nozaki Method of treating or inhibiting the development of brain inflammation and sepsis
US20050026882A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20090317476A1 (en) * 2003-07-31 2009-12-24 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
ES2371549T3 (es) * 2003-10-10 2012-01-05 Synthon B.V. Montelukast en estado sólido.
CA2554927A1 (en) * 2004-02-03 2005-08-18 Chemagis Ltd. Stable amorphous forms of montelukast sodium
US7387610B2 (en) 2004-08-19 2008-06-17 Cardiac Pacemakers, Inc. Thoracic impedance detection with blood resistivity compensation
WO2006066780A1 (en) * 2004-12-22 2006-06-29 F. Hoffmann-La Roche Ag Combinations of valategrast and montelukast for treating asthma
US20080254114A1 (en) * 2005-03-03 2008-10-16 Elan Corporation Plc Controlled Release Compositions Comprising Heterocyclic Amide Derivative Nanoparticles
BRPI0606283A2 (pt) * 2005-03-16 2009-06-09 Elan Pharma Int Ltd formulações de antagonista de receptor de leucotrieno/corticosteróide em nanopartìcula
US7603170B2 (en) * 2005-04-26 2009-10-13 Cardiac Pacemakers, Inc. Calibration of impedance monitoring of respiratory volumes using thoracic D.C. impedance
US9089275B2 (en) * 2005-05-11 2015-07-28 Cardiac Pacemakers, Inc. Sensitivity and specificity of pulmonary edema detection when using transthoracic impedance
US7907997B2 (en) * 2005-05-11 2011-03-15 Cardiac Pacemakers, Inc. Enhancements to the detection of pulmonary edema when using transthoracic impedance
JP4870402B2 (ja) * 2005-09-01 2012-02-08 小林化工株式会社 プランルカスト水和物含有錠の製造方法
US20070110802A1 (en) * 2005-11-15 2007-05-17 Janan Jona Wet granulation process
CN101426767A (zh) * 2005-11-16 2009-05-06 特瓦制药工业有限公司 经共沸除去溶剂的孟鲁司特钠干燥方法
EP1818057B1 (de) * 2006-02-09 2010-04-21 Teva Pharmaceutical Industries Ltd. Stabile pharmazeutische Zubereitungen von Montelukast-Natrium
US20090012146A1 (en) * 2007-07-02 2009-01-08 Giridhar Reddy Buggana Solubility-enhanced pharmaceutical compositions comprising zafirlukast
US8093253B2 (en) * 2008-03-06 2012-01-10 Hoffmann-La Roche Inc. Leukotriene B4 inhibitors
CN101543480A (zh) * 2008-03-28 2009-09-30 兴和株式会社 片剂
KR20130100115A (ko) 2010-08-30 2013-09-09 시누시스 코포레이션 부비강염을 치료하고 부비동 개구를 확장하기 위한 장치
EP2819740A4 (de) 2012-02-29 2015-11-25 Sinusys Corp Vorrichtungen und verfahren zur dilatation einer paranasalen sinusöffnung und zur behandlung von sinusitis
US9687263B2 (en) 2013-05-30 2017-06-27 SinuSys Corporation Devices and methods for inserting a sinus dilator
PT109030B (pt) * 2015-12-15 2019-09-25 Hovione Farmaciência, S.A. Preparação de partículas inaláveis de zafirlucaste

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL100091A (en) 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole)
US5208037A (en) * 1991-04-22 1993-05-04 Alza Corporation Dosage forms comprising polymers comprising different molecular weights
EP0641569A4 (de) 1992-03-12 1997-01-29 Ono Pharmaceutical Co Antipruritisches agens.
DE69425453T2 (de) * 1993-04-23 2001-04-12 Novartis Ag, Basel Wirkstoffabgabevorrichtung mit gesteuerter Freigabe
AU6786794A (en) * 1993-05-10 1994-12-12 Sepracor, Inc. Methods and compositions using optically pure (+)-zileuton
US5529787A (en) * 1994-07-07 1996-06-25 Alza Corporation Hydromorphone therapy
DE69617245T2 (de) 1995-08-17 2002-07-25 Csir, Pretoria Produkte mit gesteuerter freisetzung

Also Published As

Publication number Publication date
AU2882299A (en) 1999-09-20
DE69924710T2 (de) 2005-09-15
EP1059917B1 (de) 2005-04-13
ES2237088T3 (es) 2005-07-16
EP1059917A1 (de) 2000-12-20
US6224907B1 (en) 2001-05-01
ATE292960T1 (de) 2005-04-15
HK1033278A1 (en) 2001-08-24
WO1999044592A1 (en) 1999-09-10
JP2002505275A (ja) 2002-02-19
AR018582A1 (es) 2001-11-28

Similar Documents

Publication Publication Date Title
DE69924710D1 (de) Pharmazeutische zubereitung zur anwendung in der antiasthmatherapie
ATE279961T1 (de) Neue pharmazeutische zusammensetzung
ATE468324T1 (de) Pharmazeutische zusammensetzung
DE69916922D1 (de) Ibuprofenhaltige Arzneizubereitung
NO20005913L (no) Legemiddelsammensetning
DE69924999D1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
ATA1292000A (de) Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
EE200300145A (et) Asa- ja polüasanaftalenüülkarboksamiidid ja farmatseutiline kompositsioon
DE69726015D1 (de) Pharmazeutische zusammensetzung enthaltend koenzym q-10
ID27415A (id) Komposisi farmaseutik
DE60015279D1 (de) Stabilisierte pharmazeutische zusammentsetzung in lyophilisierter form
ID22565A (id) Penggunaan nanodispersi dalam formulasi akhir obat
DK1128831T3 (da) Farmaceutisk moxifloxacinpræparat
DE69925639D1 (de) Glicazidhaltige matrixtablette mit verzögerter wirkstoffverabreichung zur oralen anwendung
LV12624A (lv) Thienylazolylalcoxyethanamines their preparation and their application as medicaments
ID29262A (id) Komposisi farmasi
ID27201A (id) Komposisi farmasi
DE59910298D1 (de) Pharmazeutische levothyroxinzubereitung
ATE257700T1 (de) Pharmazeutische kombinationen mit tramadol
DE69839040D1 (de) Brunnenkresseextrakt enthaltende zubereitung zur äusserlichen anwendung
DE60129238D1 (de) Pharmazeutische zusammensetzung
DE59801987D1 (de) Pharmazeutische zusammensetzung enthaltend peptichemio
DE69830154D1 (de) Pharmazeutische zusammensetzungen
ATE251902T1 (de) Pharmazeutische zusammensetzung zur reduzierung der mcp-1 proteinsynthese
ATE208364T1 (de) A-oxo-butansäuren enthaltende pharmazeutische zusammensetzung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee